The preclinical research service for drug development has a considerable impact on the development R&D of new drugs. The range of activities in the preclinical development stage includes safety evaluation by performing in vitro and in vivo laboratory tests before human trials. Protheragen's main focus is preclinical and drug discovery services for companies that target mitochondrial diseases and support companies that are in the process of developing preclinical programs.
What is a Preclinical Research Service for Drug Development?
Preclinical development entails all processes undertaken by the pharmaceutical industry during the developmental phase of a particular therapeutic product, to ensure the product is ready for human trials. These steps might also be called preclinical research or preclinical testing.
Safety Assessment
Preclinical testing endeavors to assess a drug's safety for human application. By performing toxicological and safety tests with animal models or in vitro studies, any adverse effects or injuries that may be caused by the drug can be determined.
Drug Metabolism and Pharmacokinetic Evaluation
Preclinical testing is also utilized to assess the in vivo metabolic processes and pharmacokinetic properties of drugs. This encompasses drug absorption, distribution, metabolism, and excretion (ADME).
Efficacy Evaluation
The purpose of this procedure is to evaluate the therapeutic effect of a certain drug. Efficacy assessments through cellular models or animal experiments provide insight into the levels of selectivity and effectiveness a certain drug has on specific diseases as well as assessing its therapeutic potential.
Optimizing Drug Design
Preclinical testing facilitates the improvement of a drug's bioavailability and efficacy through the optimization of its design. By assessing structural-activity relationships between various drug molecules and their corresponding dosage forms as well as drug delivery systems, various modifications can be made to increase their effectiveness.
Our Services
Protheragen is focused on delivering tailor-made services for preclinical studies on mitochondrial diseases, guaranteeing timely delivery and accuracy of client requirements. Our highly skilled staff works closely with clients to recognize unique problems and solve them to fast-track preclinical trials through an extensive array of research services and profound guidance at this important phase of safety evaluation.
Our Advantages
Professional Team
Advanced Technology
Comprehensive Services
Reliable Data and Results
To enhance the study of mitochondrial diseases, Protheragen provides excellent preclinical research services. Our firm is committed to providing, highly specialized, skilled staff, state-of-the-art equipment, as well as effective teamwork to significantly aid in the creation of solutions for our clients and greatly support the development milestones of efficient mitochondrial disorders therapy. For any questions about our services, or to start conversations regarding possible collaboration, please feel free to contact us.
